Search

Reliance Pharma Fund Unrated

Value Research
1.05%
Change from previous, NAV as on Aug 16, 2017
Category: Equity: Pharma
Assets: R 1,470 crore (As on Jul 31, 2017)
Expense: 2.16% (As on Jul 31, 2017)
SUBSCRIBE TO THE FREE VALUE RESEARCH FUNDLINE NEWSLETTER
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers
+ Sailesh Raj Bhan since Mar 2005
comments powered by Disqus